Dellon ES - Search Results

1

Dupilumab Improves Health-Related Quality of Life and a Range of Symptoms in Patients With Eosinophilic Esophagitis.

Spergel JM, Chehade M, Dellon ES, Bredenoord AJ, Sun X, Glotfelty L, Shabbir A, Tilton ST, McCann E. Spergel JM, et al. Among authors: dellon es. Am J Gastroenterol. 2024 Dec 1;119(12):2398-2407. doi: 10.14309/ajg.0000000000002924. Epub 2024 Jun 28. Am J Gastroenterol. 2024. PMID: 38940435 Free PMC article. Clinical Trial.

2

Budesonide Oral Suspension Improves Symptomatic, Endoscopic, and Histologic Parameters Compared With Placebo in Patients With Eosinophilic Esophagitis.

Dellon ES, Katzka DA, Collins MH, Hamdani M, Gupta SK, Hirano I; MP-101-06 Investigators. Dellon ES, et al. Gastroenterology. 2017 Mar;152(4):776-786.e5. doi: 10.1053/j.gastro.2016.11.021. Epub 2016 Nov 23. Gastroenterology. 2017. PMID: 27889574 Free article. Clinical Trial.

3

Empiric elimination diets for eosinophilic esophagitis: Barriers, facilitators, and impact on quality of life.

Mehta P, Pan Z, Furuta GT, Kliewer K; Consortium of Eosinophilic Gastrointestinal Disease Researchers. Mehta P, et al. J Allergy Clin Immunol Pract. 2024 Nov 1:S2213-2198(24)01113-9. doi: 10.1016/j.jaip.2024.10.030. Online ahead of print. J Allergy Clin Immunol Pract. 2024. PMID: 39489217 No abstract available.

4

ACG Clinical Guideline: Diagnosis and Management of Eosinophilic Esophagitis.

Dellon ES, Muir AB, Katzka DA, Shah SC, Sauer BG, Aceves SS, Furuta GT, Gonsalves N, Hirano I. Dellon ES, et al. Am J Gastroenterol. 2025 Jan 1;120(1):31-59. doi: 10.14309/ajg.0000000000003194. Epub 2025 Jan 2. Am J Gastroenterol. 2025. PMID: 39745304

5

Effect of randomized treatment withdrawal of budesonide oral suspension on clinically relevant efficacy outcomes in patients with eosinophilic esophagitis: a post hoc analysis.

Dellon ES, Collins MH, Katzka DA, Mukkada VA, Falk GW, Zhang W, Goodwin B, Terreri B, Boules M, Desai NK, Hirano I. Dellon ES, et al. Therap Adv Gastroenterol. 2024 Dec 23;17:17562848241307602. doi: 10.1177/17562848241307602. eCollection 2024. Therap Adv Gastroenterol. 2024. PMID: 39735351 Free PMC article.

6

Clinical Trial: Safety and Efficacy of a Novel Oesophageal Delivery System for Topical Corticosteroids Versus Placebo in the Treatment of Eosinophilic Oesophagitis.

Lucendo AJ, Nantes-Castillejo Ó, Straumann A, Biedermann L, Bredenoord AJ, Guagnozzi D, Blas-Jhon L, Wiechowska-Kozlowska A, Weidlich S, von Arnim U, Santander-Vaquero C, Perelló A, Pérez-Martínez I, Barrio J, Vieth M, Gouya G, Dellon ES. Lucendo AJ, et al. Among authors: dellon es. Aliment Pharmacol Ther. 2024 Dec 16. doi: 10.1111/apt.18443. Online ahead of print. Aliment Pharmacol Ther. 2024. PMID: 39676687

7

High prevalence of eosinophilic gastrointestinal disorders in patients with atopic disease.

Weir AA, Iweala OI, Dellon ES. Weir AA, et al. Among authors: dellon es. Ann Allergy Asthma Immunol. 2024 Dec 9:S1081-1206(24)01724-1. doi: 10.1016/j.anai.2024.12.001. Online ahead of print. Ann Allergy Asthma Immunol. 2024. PMID: 39653145 No abstract available.

8

Development and Validation of the PICK-UP-STRICS Score to Predict Fibrostenosis in Patients with EoE Prior to Endoscopy.

Chang JW, LaFata SS, Gee TS, Redd WD, Barlowe TS, Cotton CC, Eluri S, Reed CC, Dellon ES. Chang JW, et al. Among authors: dellon es. Dig Dis Sci. 2024 Dec 6. doi: 10.1007/s10620-024-08777-z. Online ahead of print. Dig Dis Sci. 2024. PMID: 39641895

9

Effect of Esophageal Dilation History on Efficacy Outcomes in Patients With Eosinophilic Esophagitis Receiving Budesonide Oral Suspension.

Hirano I, Collins MH, Katzka DA, Mukkada VA, Falk GW, Terreri B, Boules M, Zhang W, Desai NK, Dellon ES. Hirano I, et al. Among authors: dellon es. Am J Gastroenterol. 2024 Nov 12. doi: 10.14309/ajg.0000000000003197. Online ahead of print. Am J Gastroenterol. 2024. PMID: 39631042

10

No Association Between Eosinophilic Oesophagitis and Oesophageal Cancer in US Adults: A Case-Control Study.

Albaneze N, Cotton CC, Anderson C, Katzka DA, Dellon ES. Albaneze N, et al. Among authors: dellon es. Aliment Pharmacol Ther. 2025 Jan;61(2):363-368. doi: 10.1111/apt.18431. Epub 2024 Dec 4. Aliment Pharmacol Ther. 2025. PMID: 39629856

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

524 results

Search Page

Filters